You're in a unique position to enhance your work in cancer detection and treatment through this program. It offers funding for up to three years to help you validate crucial biomarkers and assays. This financial support lets you focus on impactful research without the stress of development costs. You’ll be able to collaborate with multi-disciplinary experts, which can significantly strengthen your findings and their applicability in the healthcare community.

Participating in this program means you can take your valuable work from concept to practice, potentially improving patient diagnosis and treatment response. You'll also be able to harmonize clinical laboratory tests, ensuring that your results are reliable and reproducible across different settings. This is not just an opportunity for funding; it's a chance to make a real difference in cancer care. By applying, you position your business to lead in innovation while helping to shape the future of oncology.

Type of Financing:
This program offers grants to support your projects. Grants do not require repayment, making them an excellent opportunity for your business.

Repayment Terms and Interest Rates:
Since this is a grant, there are no repayment terms or interest rates involved. You receive the funds without having to pay them back.

Eligible Expenses:
You can use the funds for expenses related to the clinical validation of assays, including:

• Research materials and supplies
• Salaries for research team members
• Equipment and technology
• Study-related costs

Ineligible Expenses:
It’s important to note that these funds cannot be used for:

• Early-stage technology development
• Conducting clinical trials

Fees Associated with the Program:
There are no fees associated with accessing this funding. You can focus on your research without worrying about hidden costs.

• Location: Available across the country.
• Sectors: All sectors are eligible.
• Employees:
  • No minimum number of employees required.
  • No maximum number of employees required.
• Revenue:
  • No minimum revenue qualifications.
  • No maximum revenue qualifications.
• Legal Structure: All legal structures are applicable.
• Profit Structure: All profit structures are applicable.

Disqualifications:

• This program is not intended to support early-stage development of technology.
• The conduct of clinical trials is not supported; the program is focused on validation of existing assays.

This program offers you a chance to advance your work in cancer detection and treatment. You can secure funding to validate important biomarkers and assays that enhance patient diagnosis and treatment responses. This can not only boost your research but also make a significant impact in the healthcare community.

Funding is available for up to three years, allowing you to collaborate with various experts in your field. You can use the funds to support projects aimed at validating existing assays or developing new ones for clinical trials and studies. This is a great opportunity to harmonize clinical laboratory tests, ensuring reproducibility and reliability across different settings.

In essence, this program helps you put your valuable work into practice without the burden of early-stage development costs. By participating, you can focus on what matters—improving cancer care through validated research and collaboration.